NewsWhore
01-23-2009, 06:30 PM
said it has licensed two key components of an experimental leishmaniasis vaccine to research partners at the Instituto Butantan in Sao Paolo, Brazil. Under the deal, IDRI will receive royalty payments...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/21380616/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/21380616/)